BRCA Gene Testing Price: What Patients May Pay

BRCA gene testing price cannot be quoted as one standard amount because it depends on where testing is performed, whether a targeted or broader panel is used, and whether insurance or public funding applies. A genetics professional can explain likely charges before testing and help determine whether testing is medically appropriate.

BRCA testing price: why there is no single answer

The price of BRCA gene testing differs considerably between health systems and laboratories. It may be covered fully, partly covered or paid out of pocket depending on a person’s insurance plan, country of residence, referral pathway, family history and the reason testing is requested. For this reason, a clinic or laboratory should provide an individual estimate before the sample is collected.

The test may examine only a known familial BRCA variant, analyse the full BRCA1 and BRCA2 genes, or form part of a wider hereditary cancer gene panel. Broader testing and additional genetic counselling can affect the overall charge. Patients should also ask whether the estimate includes consultation, sample collection, laboratory analysis, interpretation and follow-up discussion of the results.

Price alone should not determine whether testing is pursued. The most useful test is one selected after an assessment of personal and family cancer history, because this improves the chance that the result will provide meaningful guidance.

What BRCA genetic testing looks for

BRCA1 and BRCA2 are genes involved in repairing damaged DNA. Certain inherited changes, also called pathogenic variants, can reduce this protective function and raise the lifetime risk of several cancers. These include breast and ovarian cancer, and may also include pancreatic and prostate cancer in some families.

BRCA testing does not diagnose cancer. Instead, it identifies whether a person has inherited a gene change associated with increased cancer susceptibility. A result can help guide screening, prevention discussions and, for some people with cancer, treatment planning.

It is important to distinguish inherited testing from tumour testing. Inherited, or germline, BRCA testing usually uses blood or saliva and can show a gene variant that may be present in relatives. Tumour testing examines cancer tissue for changes that developed within the tumour and may serve a different clinical purpose.

Who may be a candidate for BRCA testing

A doctor or genetic counsellor may suggest BRCA testing when a person has a personal or family pattern that could indicate hereditary cancer risk. This can include breast cancer at a young age, ovarian cancer, male breast cancer, multiple primary cancers, pancreatic cancer, aggressive prostate cancer, or several relatives with related cancers.

Testing may also be considered when a blood relative is known to carry a BRCA1 or BRCA2 variant. In that situation, a targeted test for the known family variant may be the clearest and most efficient approach. Whenever possible, testing often begins with a relative who has had cancer, since this may provide more informative results for the wider family.

Not everyone with a family history of cancer needs BRCA testing. A genetics assessment considers the types of cancer, ages at diagnosis, family relationships and ancestry, as well as previous genetic test results. This assessment can also identify when a broader hereditary cancer panel may be more suitable than BRCA-only testing.

How BRCA testing works step by step

The process generally begins with genetic counselling or a clinician-led consultation. The clinician reviews medical and family history, explains possible results and discusses how a result could affect screening, prevention choices, treatment decisions and relatives. Informed consent is obtained before testing.

A blood sample is commonly used, although some laboratories accept saliva or a cheek-swab sample. The sample is sent to a specialist laboratory, where DNA is analysed for relevant BRCA1 and BRCA2 changes. Laboratory turnaround times vary, and the ordering team will explain when the results are expected.

Results are usually reported as positive for a pathogenic or likely pathogenic variant, negative, or uncertain. A variant of uncertain significance means there is not yet enough evidence to know whether a gene change affects cancer risk. It should not usually be treated in the same way as a confirmed harmful variant. Follow-up genetic counselling helps place the result in its proper personal and family context.

For people undergoing hereditary cancer assessment, genetic counselling can provide structured support before testing and when interpreting results. It may also help patients communicate relevant information to family members.

How much does BRCA testing cost out of pocket?

There is no universal out-of-pocket BRCA testing price. Charges depend on the country, healthcare setting, laboratory, whether the test is limited to a known family variant or examines multiple genes, and whether genetic counselling is included. Insurance rules and public healthcare eligibility can also make a substantial difference.

Before booking, patients can request a written estimate that separates the laboratory fee from consultation, sample collection, interpretation and any follow-up care. They may also ask whether prior authorisation is needed, whether a referral is required, and whether the laboratory offers financial assistance or payment arrangements.

Patients should be cautious about choosing a test based only on the lowest advertised price. A reliable pathway includes appropriate clinical assessment, a validated laboratory method, clear reporting and access to qualified support for understanding the result.

Is BRCA testing worth it?

BRCA testing can be worthwhile when a person’s history suggests a meaningful possibility of inherited cancer risk, or when a known BRCA variant is present in the family. A confirmed result may allow earlier or more tailored screening, risk-reduction conversations and informed decisions for relatives. For someone already diagnosed with certain cancers, results may also contribute to treatment planning.

However, the value of testing is individual. A negative result may be reassuring in some situations, but it does not necessarily explain a strong family history or eliminate usual cancer screening needs. An uncertain result can be emotionally difficult and may not change medical care immediately.

Genetic counselling helps a person weigh potential benefits, limitations, emotional impact and family implications before deciding. The decision is not urgent for everyone, and patients can take time to ask questions and consider what information they wish to receive.

Did Angelina Jolie have BRCA1 or BRCA2?

Angelina Jolie publicly stated that she carries a BRCA1 gene mutation. Her decision to discuss preventive surgery brought wider attention to hereditary breast and ovarian cancer risk and to the role of informed personal choice.

Her experience does not mean that every person with a BRCA variant needs the same care or should make the same decisions. Cancer risk, age, medical history, family plans and personal preferences all matter. A genetics and cancer-care team can discuss options that are appropriate for each individual.

Preventive measures may include enhanced surveillance, medicines in selected circumstances, and risk-reducing surgery for some people. These are complex decisions that should be made with specialist guidance rather than on the basis of a public figure’s experience.

How to get a free BRCA test and when to seek medical care

In some countries, BRCA testing may be available without direct cost through public health services, national cancer programmes, research studies, hospital genetics clinics or insurance coverage when medical criteria are met. Eligibility differs by location and programme. A primary care doctor, oncologist, breast clinic or genetic counsellor can advise on local referral pathways.

Patients can ask their insurer or public healthcare provider whether a genetics referral is covered and what documentation is needed. If a close relative has a confirmed BRCA variant, sharing the laboratory report with the clinical team may help identify the appropriate targeted test. It is wise to confirm that any free or low-cost service includes appropriate results interpretation and follow-up.

Medical advice should be sought if a person has been diagnosed with breast, ovarian, pancreatic, prostate or male breast cancer, particularly at a younger age, or if several close relatives have had these cancers. It is also appropriate to seek advice when a relative has a known BRCA variant. Urgent care is not usually needed solely to arrange genetic testing, but new symptoms such as a breast lump, unexplained bleeding, persistent abdominal swelling or unintentional weight loss should be assessed promptly.

Acıbadem Health Point’s multidisciplinary specialists and JCI-accredited hospitals support international patients with hereditary cancer risk assessment, genetic counselling and coordinated care when needed.

Frequently asked questions